InvestorsHub Logo

raistthemage

03/31/20 10:27 PM

#259368 RE: invest2992 #259362

As if we won the patent suit but minus the 200 million or so we'd have to pay Dr Reddy and Hikma.

The point of the Teva contingency is to make sure that they will know that Teva will have the market and not Hikma or Dr. Reddy... and that as such they should settle.

But even should they not settle we'd still be better off with a generic partner than with generic competitors.